Current Prices from TVARDI THERAPEUTICS O.N.

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	TVRD	USD	12.06.2025 19:59	26,05 USD	26,03 USD +0,08 %

Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
0,00 %	-9,03 %	-2,56 %	51,84 %	30,63 %	33,59 %	39,98 %

Company Profile for TVARDI THERAPEUTICS O.N. Share

Tvardi Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. Their lead candidate, TTI-101, is currently in Phase 2 clinical trials for idiopathic pulmonary fibrosis (IPF) and hepatocellular carcinoma (HCC).

Company Data

Name TVARDI THERAPEUTICS O.N.

Company Tvardi Therapeutics, Inc.

Symbol TVRD

Website https://www.caratherapeutics.com

Primary Exchange

Frankfurt

WKN A414VY

ISIN US1407553072

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Mr. Imran Alibhai, Ph.D.

Market Capitalization 152 Mio

Country United States of America

Currency EUR

Employees 0,0 T

Address 2450 Holcombe Blvd, Suite X, 77021 Houston

IPO Date 2025-04-16

Stock Splits

Date	Split
16.04.2025	1:3

ID Changes

Date	From	To
16.04.2025	CARA	TVRD

Ticker Symbols

Name	Symbol
NASDAQ	TVRD

More Shares

Investors who TVARDI THERAPEUTICS O.N. hold also have the following shares in their portfolio:

CORERTWORK SEC. Share

NATIONAL GRID ELECTRICITY TRANSMISSION PLC RPI LKD 1.8204% INST 23/11/35 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog